연구용제품시약 > Antibody
Dupilumab CAS 1190264-60-8
TargetMoleculeCorp
Dupilumab (RegN-668) can inhibit IL-4 and IL-13 signaling pathways and significantly improve moderate to severe atopic dermatitis.It is a human monoclonal antibody (IL-4r-inhibitor) that completely inhibits il-4 receptors.
https://www.targetmol.com/compound/Dupilumab
본 정보는 "TargetMoleculeCorp" (으)로 문의 바랍니다.